{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:09:24Z","timestamp":1789034964009,"version":"build-2803163510"},"reference-count":39,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Emerging and re-emerging viral pathogens pose a persistent and significant threat to global public health and socioeconomic stability [...]<\/jats:p>","DOI":"10.3390\/ijms27188055","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:13:03Z","timestamp":1789031583000},"page":"8055","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Special Issue \u201cAntiviral Drugs Discovery\u201d"],"prefix":"10.3390","volume":"27","author":[{"given":"Sining","family":"Tao","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, Jinan 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, Jinan 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7302-2214","authenticated-orcid":false,"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, Jinan 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9232-953X","authenticated-orcid":false,"given":"Dongwei","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, Jinan 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1473-3099(08)70256-1","article-title":"Emerging infections: A perpetual challenge","volume":"8","author":"Morens","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.cell.2020.08.021","article-title":"Emerging pandemic diseases: How we got to COVID-19","volume":"182","author":"Morens","year":"2020","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e170236","DOI":"10.1172\/JCI170236","article-title":"Preparing for the next viral threat with broad-spectrum antivirals","volume":"133","author":"Karim","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: A systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"100094","DOI":"10.1016\/j.pscia.2025.100094","article-title":"Conquering viral drug resistance: Structural and mechanistic paradigms for antiresistance drug design","volume":"3","author":"Wang","year":"2025","journal-title":"Pharm. Sci. Adv."},{"key":"ref_6","unstructured":"(2024). GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet, 403, 2100\u20132132."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","article-title":"The continued threat of emerging flaviviruses","volume":"5","author":"Pierson","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41392-025-02539-7","article-title":"Antiviral drug discovery and development: Challenges and future directions","volume":"11","author":"Du","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.tim.2018.04.004","article-title":"Drug repurposing for viral infectious diseases: How far are we?","volume":"26","author":"Mercorelli","year":"2018","journal-title":"Trends Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e0007726","DOI":"10.1128\/jvi.00077-26","article-title":"Broad-acting antivirals: The pursuit of pan-viral therapeutics in the era of pandemics","volume":"100","author":"Bayurova","year":"2026","journal-title":"J. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"115726","DOI":"10.1016\/j.ejmech.2023.115726","article-title":"Natural products as potential lead compounds to develop new antiviral drugs over the past decade","volume":"260","author":"Zhao","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"152859","DOI":"10.1016\/j.ijbiomac.2026.152859","article-title":"Multi-target antiviral mechanisms of traditional chinese medicine polysaccharides against respiratory viruses: A review from structure-activity relationships to modern applications","volume":"370","author":"Zhao","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"100050","DOI":"10.1016\/j.pscia.2024.100050","article-title":"Natural product databases for drug discovery: Features and applications","volume":"2","author":"Zeng","year":"2024","journal-title":"Pharm. Sci. Adv."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1128\/JVI.01625-07","article-title":"RSV-Viral and host factors in human respiratory syncytial virus pathogenesis","volume":"82","author":"Collins","year":"2008","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virusres.2011.09.020","article-title":"RSV2-Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years","volume":"162","author":"Collins","year":"2011","journal-title":"Virus Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Gatt, D., Martin, I., AlFouzan, R., and Moraes, T.J. (2023). Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV). Pathogens, 12.","DOI":"10.3390\/pathogens12020154"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zhou, X., Du, H., Wang, C., Zhang, M., Ding, X., Wang, Y., Fan, Z., and Wang, P. (2026). Identification of a Potential Dual-Target Candidate Against RSV F Protein and 15-LOX from TCMSP: Integrating Virtual Screening, Molecular Dynamics, and Experimental Evaluation. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27083448"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Chilamakuri, R., and Agarwal, S. (2021). COVID-19: Characteristics and Therapeutics. Cells, 10.","DOI":"10.3390\/cells10020206"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11904-021-00591-w","article-title":"Socioeconomic Burdens of the COVID-19 Pandemic on LMIC Populations with Increased HIV Vulnerabilities","volume":"19","author":"McClarty","year":"2022","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e2203760119","DOI":"10.1073\/pnas.2203760119","article-title":"Interferon resistance of emerging SARS-CoV-2 variants","volume":"119","author":"Guo","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-022-05514-2","article-title":"Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir","volume":"613","author":"Iketani","year":"2023","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s42003-022-03101-9","article-title":"Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture","volume":"5","author":"Wang","year":"2022","journal-title":"Commun. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/17460441.2024.2385598","article-title":"Lessons learnt from broad-spectrum coronavirus antiviral drug discovery","volume":"19","author":"Bolinger","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Castro, J.M., Slack, R.L., Ong, Y.T., Zhang, H., Gifford, L.B., Courouble, V.V., Aiken, R.M., Shankar, V., O\u2019Leary, T.R., and Griffin, P.R. (2026). Stalling the Enemy: Targeting Nsp13 for Next-Generation SARS-CoV-2 Antivirals. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27062587"},{"key":"ref_25","first-page":"162","article-title":"SARS-CoV-2 variant biology: Immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Dinata, R., Baindara, P., and Mandal, S.M. (2025). Evolution of Antiviral Drug Resistance in SARS-CoV-2. Viruses, 17.","DOI":"10.3390\/v17050722"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"102829","DOI":"10.1016\/j.sbi.2024.102829","article-title":"Structure-based virtual screening of vast chemical space as a starting point for drug discovery","volume":"87","author":"Carlsson","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"102812","DOI":"10.1016\/j.sbi.2024.102812","article-title":"Emerging structure-based computational methods to screen the exploding accessible chemical space","volume":"86","author":"Bedart","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Jing, L., Zhao, F., Zheng, L., Meng, B., Gao, S., Laporte, M., Jochmans, D., De Jonghe, S., Neyts, J., and Zhan, P. (2025). Optimization of SARS-CoV-2 mpro inhibitors by a structure-based multilevel virtual screening method. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020670"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/CMR.00072-15","article-title":"Zika virus","volume":"29","author":"Musso","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s44360-026-00156-4","article-title":"A decade of progress and persistent challenges following the public health emergency of zika virus","volume":"1","author":"Rojas","year":"2026","journal-title":"Nat. Health"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Komarasamy, T.V., Adnan, N.A.A., James, W., and Balasubramaniam, V.R. (2022). Finding a chink in the armor: Update, limitations, and challenges toward successful antivirals against flaviviruses. PLoS Neglected Trop. Dis., 16.","DOI":"10.1371\/journal.pntd.0010291"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3201\/eid2207.151990","article-title":"A Literature Review of Zika Virus","volume":"22","author":"Plourde","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"105517","DOI":"10.1016\/j.antiviral.2022.105517","article-title":"Therapeutics for flaviviral infections","volume":"210","author":"Bifani","year":"2023","journal-title":"Antivir. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrd.2017.33","article-title":"Broad-spectrum agents for flaviviral infections: Dengue, Zika and beyond","volume":"16","author":"Boldescu","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Murineddu, G., Plicanti, E., Corona, P., Di Marzo, C., Asproni, B., Lupinu, I., Lottini, G., Piras, S., and Carta, A. (2026). Tricyclic Pyrrole-Based Compounds as Zika Virus Inhibitors. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27052306"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Zhang, M., Zhong, J., Xiong, Y., Song, X., Li, C., and He, Z. (2021). Development of Broad-Spectrum Antiviral Agents-Inspiration from Immunomodulatory Natural Products. Viruses, 13.","DOI":"10.3390\/v13071257"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Schiffmann, S., Henke, M., Br\u00fcnner, S., Bennett, A., Yagubi, Y., Magari, F., Parnham, M.J., and Gr\u00fcnweller, A. (2024). Immune modulatory profile of the pateamines PatA and des-methyl des-amino PatA. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252111430"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8055\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:19:25Z","timestamp":1789031965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":39,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27188055"],"URL":"https:\/\/doi.org\/10.3390\/ijms27188055","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}